Testosterone/androstenedione ratio in the evaluation of women with ovarian androgen excess

Obstet Gynecol. 1983 Mar;61(3):279-84.

Abstract

A plasma testosterone/androstenedione (T/A) ratio was calculated in 15 women with possible ovarian neoplasms and androgen excess and whose mean plasma concentration of testosterone approached or was greater than a twofold elevation. The T/A ratio approached unity in eight of nine patients with polycystic ovarian disease, whereas all patients with hyperthecosis and two of three patients with androgen-secreting tumors had a testosterone/androstenedione ratio above 1.5. In 13 of 16 patients with androgen-secreting tumors of the ovary reported in the literature, the testosterone/androstenedione ratio was above 1.5. An elevated testosterone/androstenedione ratio should raise the suspicion of either an ovarian androgen-secreting tumor or hyperthecosis.

MeSH terms

  • Adolescent
  • Adult
  • Androstenedione / blood*
  • Dehydroepiandrosterone / analogs & derivatives
  • Dehydroepiandrosterone / blood
  • Dehydroepiandrosterone Sulfate
  • Female
  • Humans
  • Hyperplasia
  • Leydig Cell Tumor / blood
  • Middle Aged
  • Ovarian Cysts / blood*
  • Ovarian Neoplasms / blood*
  • Ovary / pathology
  • Sertoli-Leydig Cell Tumor / blood
  • Testosterone / blood*

Substances

  • Testosterone
  • Androstenedione
  • Dehydroepiandrosterone
  • Dehydroepiandrosterone Sulfate